期刊文献+

血浆置换联合连续血液滤过救治小儿溶血尿毒综合征的机制探讨 被引量:3

Mechanism of Sequential Plasma Exchange and Continuous Blood Purification in the Treatment of Children Hemolytic Uremic Syndrome
下载PDF
导出
摘要 血浆置换(PE)联合连续血液净化(CBP)对小儿溶血尿毒综合征(HUS)的疗效观察及机制探讨。回顾性分析21例重型HUS患儿在内科综合治疗同时,采用序贯血浆置换(PE)加连续性静-静脉血液滤过(CVVH)治疗前后生命体征、炎性细胞因子、生化指标等的变化。经序贯PE加CBP治疗后患儿全身状况迅速改善,溶血控制,尿量增加,肾及其他各脏器功能检测指标逐步恢复正常,治疗前后炎性细胞因子、生化指标等具有显著差异。说明PE联合CBP救治重型溶血尿毒综合征能显著清除致病性细胞因子,稳定内环境,改善内皮细胞功能增强疗效,尽早治疗可缩短病程,改善预后。 To discuss the mechanism of sequential plasma exchange(PE) and continuous blood purification(CBP) in the treatment of children hemolytic uremic syndrome(HUS) as well as the therapeutic effectiveness.The change in vital sign,some cytokine and biochemical indicator before and after PE+CBP treatment in 21 cases of HUS with conventional treatment were analyzed.After PE+CBP,rapid improvement occurred in systematic conditions,hemolytic control,urine increase.Functions of kidney and other organs gradually recovered to normal,they were all survived patients at acute phase and hemolytic control,the function of kidney and other organ recovered.There were significantly differences in some cytokine and biochemical indicator before and after PE and CBP treatment.PE+CBP treat hemolytic uremic syndrome can significantly remove some of the pathogenic cytokines,stablize internal environment,improve endothelial cell function to enhance efficacy,early treatment can shorten the course of the disease and improve prognosis.
机构地区 济南军区总院
出处 《生物医学工程研究》 2011年第1期46-48,55,共4页 Journal Of Biomedical Engineering Research
关键词 血浆置换 连续血液净化 溶血尿毒综合征 小儿 内皮细胞 Plasma exchange Continuous blood purification Hemolytic uremic syndrome Paediatrics Vascular endothelial cells
  • 相关文献

参考文献4

二级参考文献12

共引文献13

同被引文献39

  • 1伦立德,朱晓明,李伟生,白玲,孙红,张跃文,杨爱军,桑树余.双重血浆分离治疗溶血性尿毒症综合征[J].中国血液净化,2002,1(9):14-16. 被引量:4
  • 2李丹丹,孟建中,吕苏一,荣鹏,徐建江,王扬,李新立,张洪彬,高利群.野外演练致劳力性热射病的多器官功能损伤的规律及高危因素[J].生物医学工程研究,2010,29(4):263-267. 被引量:20
  • 3葛伟,孙若鹏.小儿溶血尿毒综合征10例临床分析[J].临床儿科杂志,2007,25(10):844-847. 被引量:5
  • 4Szczepiorkowski ZM, Winters JL,Bandarenko N, et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based ap- proach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher, 2010,25 : 83-177. 被引量:1
  • 5de Lind van Wijngaarden RA, Hauer HA, Wolterbeek R, et al. Clinical and histologie determinants of renal outcome in ANCA- associated vaseulitis:A prospective analysis of 100 patients with severe renal involvement. J Am Soc Nephrol, 2006, 17: 2264- 2274. 被引量:1
  • 6Guyatt GH, Cook DJ, Jaeschke R, et al. Grades of recommenda- tion for antithrombotic agents:American College of Chest Physi- cians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest,2008,133(6 Suppl) : 123S-131S. 被引量:1
  • 7Guyatt G,Gutterman D, Baumann MH, et al. Grading strength of recommendations and quality of evidence in clinical guidelines: Report from an american college of chest physicians task force. Chest,2006,129 : 174-181. 被引量:1
  • 8Mukhtyar C, Guillevin L, Cid MC, et al. EULAR recommenda- tions for the management of primary small and medium vessel vaseulitis. Ann Rheum Dis, 2009,68 : 310-317. 被引量:1
  • 9Hirai Y, Iyoda M, Shibata T, et al. Lupus nephritis associated with positive MPO-ANCA in a patient with underlying autoim- mune hemolytic anemia. Clin Exp Nephrol, 2008,12 : 393-397. 被引量:1
  • 10Mahr A, Chaigne-Delalande S, De Menthon M. Therapeutic plas- ma exchange in systemic vasculitis: An update on indications and results. Curr Opin Rheumatol, 2012,24 : 261-266. 被引量:1

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部